Concepedia

Tsuei-Ju Wu

TW

13

Publications

1.9K

Citations

12

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Arena Pharmaceuticals (United States)

Tsuei-Ju Wu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1988–2012

13

Publications

13

(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G

Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan et al. · Journal of Biological Chemistry · 2005 · 636 citations · Full text

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 362 citations · Full text

Antagonism of the prostaglandin D <sub>2</sub> receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans

Kang Cheng, Tsuei-Ju Wu, Kenneth K. Wu et al. · Proceedings of the National Academy of Sciences · 2006 · 268 citations · Full text

, , +15

Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2

Lihu Yang, Scott C. Berk, Susan P. Rohrer et al. · Proceedings of the National Academy of Sciences · 1998 · 128 citations · Full text

Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression

Brett Lauring, Andrew K.P. Taggart, James R. Tata et al. · Science Translational Medicine · 2012 · 125 citations

Rows per page

1–5 of 13